Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Non Operating Income (2024 - 2025)

Allarity Therapeutics' Non Operating Income history spans 2 years, with the latest figure at -$455000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 234.56% year-over-year to -$455000.0; the TTM value through Dec 2025 reached $1.4 million, down 41.41%, while the annual FY2025 figure was $1.4 million, 41.41% down from the prior year.
  • Non Operating Income reached -$455000.0 in Q4 2025 per ALLR's latest filing, down from -$288000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.8 million in Q2 2025 to a low of -$455000.0 in Q4 2025.